| Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer CG Gerestein, GM Nieuwenhuyzen-de Boer, MJ Eijkemans, GS Kooi, ... European journal of cancer 46 (1), 102-109, 2010 | 76 | 2010 |
| Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high … MG Dijkstra, DAM Heideman, FJ van Kemenade, KJA Hogewoning, ... Journal of clinical virology 54 (2), 147-151, 2012 | 68 | 2012 |
| Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis M Kengsakul, GM Nieuwenhuyzen-de Boer, S Udomkarnjananun, SJ Kerr, ... Journal of Gynecologic Oncology 33 (4), 2022 | 23 | 2022 |
| Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial … GM Nieuwenhuyzen-de Boer, W Hofhuis, N Reesink-Peters, ... BMC cancer 19, 1-7, 2019 | 23 | 2019 |
| Adjuvant use of PlasmaJet device during cytoreductive surgery for advanced-stage ovarian cancer: results of the PlaComOv-study, a randomized controlled trial in the Netherlands GM Nieuwenhuyzen-de Boer, W Hofhuis, N Reesink-Peters, S Willemsen, ... Annals of Surgical Oncology 29 (8), 4833-4843, 2022 | 14 | 2022 |
| Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer GM Nieuwenhuyzen-de Boer, CG Gerestein, MJ Eijkemans, CW Burger, ... Eur J Gynaecol Oncol 37 (1), 63-8, 2016 | 13 | 2016 |
| Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review GM Nieuwenhuyzen-de Boer, J van der Kooy, HJ van Beekhuizen Journal of Ovarian Research 12, 1-3, 2019 | 12 | 2019 |
| Hyperspectral imaging for tissue classification after advanced stage ovarian cancer surgery—A pilot study SM van Vliet-Pérez, NJ van de Berg, F Manni, M Lai, L Rijstenberg, ... Cancers 14 (6), 1422, 2022 | 11 | 2022 |
| Pfeiffer syndrome: the importance of prenatal diagnosis GM Nieuwenhuyzen-De Boer, AJM Hoogeboom, LS Smit, R Heydanus, ... European Journal of Obstetrics and Gynecology and Reproductive Biology 181 …, 2014 | 10 | 2014 |
| Survival in advanced-stage epithelial ovarian cancer patients with cardiophrenic lymphadenopathy who underwent cytoreductive surgery: A systematic review and meta-analysis M Kengsakul, GM Nieuwenhuyzen-de Boer, AHJ Bijleveld, ... Cancers 13 (19), 5017, 2021 | 8 | 2021 |
| Adenoid cystic carcinoma of the Bartholin gland is not HPV-related: a case report and review of literature GM Nieuwenhuyzen-de Boer, S Dasgupta, PC Ewing-Graham, ... Pathology-Research and Practice 216 (6), 152968, 2020 | 8 | 2020 |
| Factors Predicting 30-Day Grade IIIa–V Clavien–Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian … M Kengsakul, GM Nieuwenhuyzen-de Boer, S Udomkarnjananun, SJ Kerr, ... Cancers 14 (17), 4181, 2022 | 6 | 2022 |
| Preoperative cancer antigen 125 level as predictor for complete cytoreduction in ovarian cancer: a prospective cohort study and systematic review PE Brons, GM Nieuwenhuyzen-de Boer, C Ramakers, S Willemsen, ... Cancers 14 (23), 5734, 2022 | 5 | 2022 |
| The effects of neutral argon plasma versus electrocoagulation on tissue in advanced-stage ovarian cancer: A case series GM Nieuwenhuyzen-de Boer, NJ van de Berg, XS Gao, ... Journal of Ovarian Research 15 (1), 140, 2022 | 4 | 2022 |
| Cost Study of the PlasmaJet Surgical Device Versus Conventional Cytoreductive Surgery in Patients With Advanced-Stage Ovarian Cancer GM Nieuwenhuyzen-de Boer, AJLM Geraerds, MH van der Linden, ... JCO Clinical Cancer Informatics 6, e2200076, 2022 | 4 | 2022 |
| Clinical validation and comparison of the Comprehensive Complication Index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in … M Kengsakul, GM Nieuwenhuyzen-de Boer, S Udomkarnjananun, SJ Kerr, ... International Journal of Gynecologic Cancer 33 (2), 2023 | 2 | 2023 |
| Anemia and Trombocytopenia after Delivery: A Case Study of Trombotic Trombocytopenic Purpura GM Nieuwenhuyzen-de Boer, MA Kamping, S Kersting, A Dijkman Waterloo, Canada: Open Access Text, 0 | 2 | |
| Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients GM Nieuwenhuyzen-de Boer, H Aamran, CB van den Berg, S Willemsen, ... Cancers 15 (15), 3947, 2023 | 1 | 2023 |
| ASO Author Reflections: The PlasmaJet® Device Contributes to an Increase in the Number of Complete Cytoreductive Surgeries for Ovarian Cancer Patients GM Nieuwenhuyzen-de Boer, HJ Van Beekhuizen Annals of Surgical Oncology 29 (8), 4844-4845, 2022 | 1 | 2022 |
| The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks HS Zelisse, S de Ridder, MDJM van Gent, CH Mom, GBA Wisman, ... Biopreservation and biobanking, 2024 | | 2024 |
